75% of our users have never heard of HIMSS before. We thought people would use HIMSS first and then do the surgical step, but that's not the case. So we're not only profitable on the first transaction, but we can get this recurring motion going.

Seventy five percent of our users have never heard of HIMSS before, which really surprised us because we thought people would use HIMSS first and then do the surgical step, but that's not the case. So now we're partnering with companies like Honeybee Health and MDI to be able to prescribe and deliver these drugs to our users. So not only are we profitable on the first transaction, but we can get this recurring motion going as well. And you're doing that today? We're one of the primary reasons we're fundraising is so we can meet the insurance minimums in order to get into medication.

Got it. Okay.

Can you talk a little bit about the fundraising plan?

We're raising a million pre seed. We have 850 k committed already. We're willing to oversubscribe for you guys.